featured
Semaglutide vs Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes Care
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
A 26-Week Randomized Controlled Trial of Semaglutide Once Daily Versus Liraglutide and Placebo in Patients With Type 2 Diabetes Suboptimally Controlled on Diet and Exercise With or Without Metformin
Diabetes Care 2018 Jul 19;[EPub Ahead of Print], I Lingvay, CV Desouza, KS Lalic, L Rose, T Hansen, J Zacho, TR PieberFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.